{"id":46935,"date":"2022-08-04T14:01:44","date_gmt":"2022-08-04T12:01:44","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/endra-life-sciences-to-report-second-quarter-2022-financial-results-on-august-15-2022\/"},"modified":"2022-08-04T14:01:44","modified_gmt":"2022-08-04T12:01:44","slug":"endra-life-sciences-to-report-second-quarter-2022-financial-results-on-august-15-2022","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/endra-life-sciences-to-report-second-quarter-2022-financial-results-on-august-15-2022\/","title":{"rendered":"ENDRA Life Sciences to Report Second Quarter 2022 Financial Results on August 15, 2022"},"content":{"rendered":"
\n

ANN ARBOR, Mich.–(BUSINESS WIRE)–$NDRA<\/a> #NALFD<\/a>—ENDRA Life Sciences Inc.<\/a> (ENDRA) (NASDAQ: NDRA), a pioneer of enhanced ultrasound technologies, today announced that the company will report financial results for the second quarter of 2022 on Monday, August 15, 2022 after the close of trading on the U.S. financial markets. Management will host a conference call and webcast beginning at 4:30 p.m. Eastern time to discuss the results, provide an update on recent corporate developments and answer questions.\n<\/p>\n

\nParticipants are encouraged to pre-register for the conference call using this link<\/a>. Callers who pre-register will be given a unique PIN to gain immediate access to the call and bypass the live operator. Participants may register at any time, including up to and after the call start time. Those unable to pre-register may participate by dialing (844) 868-8846 (U.S.) or (412) 317-5465 (International). A webcast of the call may also be accessed at ENDRA\u2019s Investor Relations page<\/a> and here<\/a>.\n<\/p>\n

\nA telephone replay will be available until August 22, 2022 by dialing (877) 344-7529 (U.S.) or (412) 317-0088 (International) and providing the passcode 1237055. A webcast replay will be available beginning approximately one hour after the completion of the live conference call here<\/a>.\n<\/p>\n

\nAbout ENDRA Life Sciences Inc.<\/b>\n<\/p>\n

\nENDRA Life Sciences is the pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS\u00ae<\/sup>), a ground-breaking technology being developed to visualize tissue like MRI, but at 1\/50th the cost and at the point of patient care. TAEUS\u00ae<\/sup> is designed to work in concert with over 500,000 ultrasound systems in use globally today. TAEUS\u00ae<\/sup> is initially focused on the measurement of fat in the liver as a means to assess and monitor Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH), chronic liver conditions that affect over one billion people globally, and for which there are no practical diagnostic tools. Beyond the liver, ENDRA is exploring several other clinical applications of TAEUS\u00ae<\/sup>, including visualization of tissue temperature during energy-based surgical procedures. For more information, please visit www.endrainc.com<\/a>.\n<\/p>\n

Contacts<\/b> <\/p>\n

\nCompany Contact:<\/b>
Irina Pestrikova
\n
Senior Director, Finance
\n
investors@endrainc.com<\/a>
www.endrainc.com<\/a>\n<\/p>\n

\nInvestor Relations Contact:<\/b>
Yvonne Briggs
\n
LHA Investor Relations
\n
(310) 691-7100
\n
ybriggs@lhai.com<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

ANN ARBOR, Mich.–(BUSINESS WIRE)–$NDRA #NALFD—ENDRA Life Sciences Inc. (ENDRA) (NASDAQ: NDRA), a pioneer of enhanced ultrasound technologies, today announced that the company will report financial results for the second quarter of 2022 on Monday, August 15, 2022 after the close of trading on the U.S. financial markets. Management will host a conference call and webcast … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-46935","6":"format-standard","7":"category-industry"},"yoast_head":"\nENDRA Life Sciences to Report Second Quarter 2022 Financial Results on August 15, 2022 - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/endra-life-sciences-to-report-second-quarter-2022-financial-results-on-august-15-2022\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"ENDRA Life Sciences to Report Second Quarter 2022 Financial Results on August 15, 2022 - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"ANN ARBOR, Mich.–(BUSINESS WIRE)–$NDRA #NALFD—ENDRA Life Sciences Inc. (ENDRA) (NASDAQ: NDRA), a pioneer of enhanced ultrasound technologies, today announced that the company will report financial results for the second quarter of 2022 on Monday, August 15, 2022 after the close of trading on the U.S. financial markets. Management will host a conference call and webcast ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/endra-life-sciences-to-report-second-quarter-2022-financial-results-on-august-15-2022\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-08-04T12:01:44+00:00\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/endra-life-sciences-to-report-second-quarter-2022-financial-results-on-august-15-2022\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/endra-life-sciences-to-report-second-quarter-2022-financial-results-on-august-15-2022\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"ENDRA Life Sciences to Report Second Quarter 2022 Financial Results on August 15, 2022\",\"datePublished\":\"2022-08-04T12:01:44+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/endra-life-sciences-to-report-second-quarter-2022-financial-results-on-august-15-2022\\\/\"},\"wordCount\":362,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/endra-life-sciences-to-report-second-quarter-2022-financial-results-on-august-15-2022\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/endra-life-sciences-to-report-second-quarter-2022-financial-results-on-august-15-2022\\\/\",\"name\":\"ENDRA Life Sciences to Report Second Quarter 2022 Financial Results on August 15, 2022 - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"datePublished\":\"2022-08-04T12:01:44+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/endra-life-sciences-to-report-second-quarter-2022-financial-results-on-august-15-2022\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/endra-life-sciences-to-report-second-quarter-2022-financial-results-on-august-15-2022\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/endra-life-sciences-to-report-second-quarter-2022-financial-results-on-august-15-2022\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"ENDRA Life Sciences to Report Second Quarter 2022 Financial Results on August 15, 2022\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"ENDRA Life Sciences to Report Second Quarter 2022 Financial Results on August 15, 2022 - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/endra-life-sciences-to-report-second-quarter-2022-financial-results-on-august-15-2022\/","og_locale":"en_US","og_type":"article","og_title":"ENDRA Life Sciences to Report Second Quarter 2022 Financial Results on August 15, 2022 - Pharma Trend","og_description":"ANN ARBOR, Mich.–(BUSINESS WIRE)–$NDRA #NALFD—ENDRA Life Sciences Inc. (ENDRA) (NASDAQ: NDRA), a pioneer of enhanced ultrasound technologies, today announced that the company will report financial results for the second quarter of 2022 on Monday, August 15, 2022 after the close of trading on the U.S. financial markets. Management will host a conference call and webcast ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/endra-life-sciences-to-report-second-quarter-2022-financial-results-on-august-15-2022\/","og_site_name":"Pharma Trend","article_published_time":"2022-08-04T12:01:44+00:00","author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/endra-life-sciences-to-report-second-quarter-2022-financial-results-on-august-15-2022\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/endra-life-sciences-to-report-second-quarter-2022-financial-results-on-august-15-2022\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"ENDRA Life Sciences to Report Second Quarter 2022 Financial Results on August 15, 2022","datePublished":"2022-08-04T12:01:44+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/endra-life-sciences-to-report-second-quarter-2022-financial-results-on-august-15-2022\/"},"wordCount":362,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/endra-life-sciences-to-report-second-quarter-2022-financial-results-on-august-15-2022\/","url":"https:\/\/pharma-trend.com\/en\/endra-life-sciences-to-report-second-quarter-2022-financial-results-on-august-15-2022\/","name":"ENDRA Life Sciences to Report Second Quarter 2022 Financial Results on August 15, 2022 - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"datePublished":"2022-08-04T12:01:44+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/endra-life-sciences-to-report-second-quarter-2022-financial-results-on-august-15-2022\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/endra-life-sciences-to-report-second-quarter-2022-financial-results-on-august-15-2022\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/endra-life-sciences-to-report-second-quarter-2022-financial-results-on-august-15-2022\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"ENDRA Life Sciences to Report Second Quarter 2022 Financial Results on August 15, 2022"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/46935","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=46935"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/46935\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=46935"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=46935"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=46935"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}